[{"innerBlocks":[],"name":"core\/freeform","postId":870,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"New York City\u2019s largest integrated delivery system is looking to put its healthcare data front and center in its efforts to improve patient care with the creation of a new executive-level position.

Mount Sinai Health System announced on Wednesday that Andrew Kasarskis, an internationally recognized expert in biomedical data, has been named executive vice president and chief data officer.

\u201cThe CDO position will play a crucial role in continuously advancing Mount Sinai\u2019s capabilities for our patients and the entire healthcare system,\u201d said Kenneth Davis, MD, president and CEO of the Mount Sinai Health System.

\u201cWe knew we needed a leader with deep expertise in the development of medical and research technologies that can harness information and deliver invaluable insights into the genetics and pathology of diseases, which is a rare combination of expertise to find,\u201d Davis added. \u201cWe are excited about Dr. Kasarskis\u2019s vision to encourage more data-driven commercial partnerships, spinoffs and patient initiatives to address healthcare needs.\u201d

Also See<\/b>: Mount Sinai is home to new institute for digital health<\/a>

According to Mount Sinai, Kasarskis will spearhead leveraging the healthcare organization\u2019s digital assets to include supporting entrepreneurial activities at the Icahn School of Medicine at Mount Sinai, as well as adopting key performance metrics to measure infrastructure improvements and data-driven projects.

\u201cThe addition of this role at Mount Sinai provides an exceptional opportunity to strengthen our healthcare system\u2019s overall data literacy and culture,\u201d said Kasarskis. \u201cI want everyone here to view the vast data available to us as an asset we can use objectively to improve efficiency and quality of care, identify patient cohorts for groundbreaking research, enhance the education we provide trainees through the Icahn School of Medicine at Mount Sinai and add value to all of our organizational efforts.\u201d

Previously, Kasarskis served as director of the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine. While he has stepped down from those roles, Kasarskis will remain a professor in the Department of Genetics and Genomic Sciences and will continue to conduct research in the development and application of technology in areas such as pathogen surveillance, pharmacogenomics, viral infections, and chronic disease.

\u201cBy building a data-driven environment where we can assess hospital initiatives for impact, we can achieve a much faster loop to identify treatment-related issues and opportunities, access the necessary data to address them, conceptualize interventions that have the potential to deliver positive patient outcomes, and realize the benefits more quickly and to a much greater extent than was previously possible,\u201d added Kasarskis.","saveContent":"New York City\u2019s largest integrated delivery system is looking to put its healthcare data front and center in its efforts to improve patient care with the creation of a new executive-level position.

Mount Sinai Health System announced on Wednesday that Andrew Kasarskis, an internationally recognized expert in biomedical data, has been named executive vice president and chief data officer.

\u201cThe CDO position will play a crucial role in continuously advancing Mount Sinai\u2019s capabilities for our patients and the entire healthcare system,\u201d said Kenneth Davis, MD, president and CEO of the Mount Sinai Health System.

\u201cWe knew we needed a leader with deep expertise in the development of medical and research technologies that can harness information and deliver invaluable insights into the genetics and pathology of diseases, which is a rare combination of expertise to find,\u201d Davis added. \u201cWe are excited about Dr. Kasarskis\u2019s vision to encourage more data-driven commercial partnerships, spinoffs and patient initiatives to address healthcare needs.\u201d

Also See<\/b>: Mount Sinai is home to new institute for digital health<\/a>

According to Mount Sinai, Kasarskis will spearhead leveraging the healthcare organization\u2019s digital assets to include supporting entrepreneurial activities at the Icahn School of Medicine at Mount Sinai, as well as adopting key performance metrics to measure infrastructure improvements and data-driven projects.

\u201cThe addition of this role at Mount Sinai provides an exceptional opportunity to strengthen our healthcare system\u2019s overall data literacy and culture,\u201d said Kasarskis. \u201cI want everyone here to view the vast data available to us as an asset we can use objectively to improve efficiency and quality of care, identify patient cohorts for groundbreaking research, enhance the education we provide trainees through the Icahn School of Medicine at Mount Sinai and add value to all of our organizational efforts.\u201d

Previously, Kasarskis served as director of the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine. While he has stepped down from those roles, Kasarskis will remain a professor in the Department of Genetics and Genomic Sciences and will continue to conduct research in the development and application of technology in areas such as pathogen surveillance, pharmacogenomics, viral infections, and chronic disease.

\u201cBy building a data-driven environment where we can assess hospital initiatives for impact, we can achieve a much faster loop to identify treatment-related issues and opportunities, access the necessary data to address them, conceptualize interventions that have the potential to deliver positive patient outcomes, and realize the benefits more quickly and to a much greater extent than was previously possible,\u201d added Kasarskis.","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Mount Sinai creates Chief Data Officer role, appoints Kasarskis

More for you